Nanalysis Scientific's earnings before interest and taxes (EBIT) for the
three
months ended in Mar. 2026 was $-0.65 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $-3.11 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Nanalysis Scientific's annualizedROC % for the quarter that ended in Mar. 2026 was -11.04%.
Nanalysis Scientific's annualizedROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -37.78%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
Nanalysis Scientific's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -13.33%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Scientific & Technical Instruments subindustry, Nanalysis Scientific's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanalysis Scientific EV-to-EBIT vs Hardware Industry
For the Hardware industry and Technology sector, Nanalysis Scientific's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Nanalysis Scientific's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.11 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nanalysis Scientific (NSCIF) has a EBIT of $-3.11 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nanalysis Scientific.
Is Nanalysis Scientific's EBIT too high?
Nanalysis Scientific's current EBIT is $-3.11 Mil. Overall, Nanalysis Scientific has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nanalysis Scientific's EBIT compare to COHR and KEYS?
Nanalysis Scientific's EBIT of $-3.11 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Hardware company?
A good EBIT depends on the Hardware industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nanalysis Scientific. Nanalysis Scientific's current EBIT is $-3.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanalysis Scientific stock overvalued right now?
Based on GuruFocus' analysis, Nanalysis Scientific (NSCIF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.22, compared to a current price of $0.08 — trading 62.2% below its estimated fair value. The current EBIT is $-3.11 Mil. Nanalysis Scientific's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Nanalysis Scientific (NSCIF), the current EBIT is $-3.11 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nanalysis Scientific (NSCIF) Overvalued in 2026?
Based on GuruFocus' analysis, Nanalysis Scientific stock appears to be undervalued.
The current stock price of $0.08 is trading 62.2% below its estimated GF Value™ of $0.22.
GuruFocus considers Nanalysis Scientific to be Possible Value Trap.
Key valuation signals for NSCIF:
EBIT: $-3.11 Mil
GF Value™: $0.22 vs. price of $0.08 (62.2% below fair value)
No single metric tells the full story. See the NSCIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nanalysis Scientific Corp has two primary operating segments. Its first operating segment, Scientific Equipment, conducts scientific equipment manufacturing and sales, mainly as a patent-protected technology company that develops, manufactures, and sells magnetic resonance products for education, pharmaceutical, biotech, nutraceutical, chemical, food, materials, security, life science, and medical applications. Its second operating segment, Security Services, focuses on providing preventative and on-call maintenance services, as well as installation of detection and analysis equipment. The majority of this segment consists of servicing a Crown Corporation of the Government of Canada, maintaining imaging and security equipment at international airports across Canada.
53GF Score
Get the complete analysis for NSCIF
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSCIF has been successfully added to your 
